Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 26, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	632	649	2,239	1,934	1,044	217
Market Cap Growth	-77.43%	-71.00%	15.76%	85.28%	380.31%	614.33%
Enterprise Value	2,011	1,563	3,040	2,313	1,221	223
Last Close Price	13.87	14.26	49.17	56.51	30.50	6.35
PE Ratio	-	-	35.18	22.14	23.76	-
PS Ratio	0.48	0.50	1.35	1.19	1.70	1.03
PB Ratio	0.63	0.65	2.94	4.00	4.25	1.08
P/TBV Ratio	1.28	1.32	5.10	8.61	5.14	1.37
P/FCF Ratio	-	-	-	-	35.73	-
P/OCF Ratio	-	-	-	11.95	25.39	84.93
EV/Sales Ratio	1.54	1.20	1.83	1.42	1.98	1.05
EV/EBITDA Ratio	21.43	16.65	12.43	12.83	17.76	-
EV/EBIT Ratio	33.42	25.96	14.72	15.76	19.64	-
EV/FCF Ratio	-24.78	-	-	-	41.79	-
Debt / Equity Ratio	1.37	1.37	1.48	1.45	0.77	0.77
Debt / EBITDA Ratio	14.60	14.60	4.60	3.89	2.73	-
Debt / FCF Ratio	-	-	-	-	6.43	-
Asset Turnover	0.52	0.52	0.85	1.57	1.35	0.46
Inventory Turnover	1.98	1.98	3.61	15.12	31.58	5.22
Quick Ratio	0.83	0.83	1.08	0.84	0.90	0.59
Current Ratio	1.74	1.74	1.67	1.08	1.01	0.78
Return on Equity (ROE)	-6.93%	-6.93%	16.73%	32.72%	19.89%	-44.05%
Return on Assets (ROA)	1.49%	1.49%	6.60%	8.85%	8.50%	-7.25%
Return on Capital (ROIC)	1.77%	1.77%	8.40%	11.33%	9.84%	-8.27%
Return on Capital Employed (ROCE)	3.60%	3.60%	14.00%	17.50%	19.50%	-
Earnings Yield	-9.67%	-9.41%	2.84%	4.52%	4.21%	-51.60%
FCF Yield	-12.85%	-12.50%	-20.92%	-2.76%	2.80%	-2.02%
Buyback Yield / Dilution	15.51%	-16.18%	10.44%	-27.02%	3.86%	-878.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.